Analyzing changes in retained earnings. Johnson & Johnson, a pharmaceutical and medical products company, reported a balance in retained earnings of $23,066 million at the beginning of Year 12 and $26,571 million at the end of Year 12. It reported dividends declared and paid of

$3,092 million for Year 12. Compute the amount of net income for Year 12.